Teva’s CEO Richard Francis is adding to his constellation of new executives with a fresh business development hire from BeiGene. | Teva has enlisted BeiGene’s Angus Grant, Ph.D. as its EVP of business development, the Israeli-American generics giant announced Friday. It was during Grant’s tenure as chief business executive that BeiGene signed the high-profile PD-1 and TIGIT pacts with Novartis.
